Principia Wealth Advisory’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Principia Wealth Advisory's IONS Position: Q3 2026 in Review
Principia Wealth Advisory increased its Ionis Pharmaceuticals (IONS) stake by 9.4% in Q3 2026, buying an estimated $170 and bringing the position to 35 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #664.
Principia Wealth Advisory first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.54K in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Principia Wealth Advisory held 35 shares of Ionis Pharmaceuticals worth $1.56K as of Q3 2026.
- Principia Wealth Advisory bought 3 Ionis Pharmaceuticals shares in Q3 2026, an estimated $170.
- Ionis Pharmaceuticals made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q3 2026, its #664 holding.
- Principia Wealth Advisory first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- Principia Wealth Advisory's Ionis Pharmaceuticals position peaked at $2.54K in Q2 2026.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Principia Wealth Advisory's 13F filing for Q3 2026, filed 12 Nov 2026.